An animal study of the effects on p16 and PCNA expression of repeated treatment with high-energy laser and intense pulsed light exposure

Lasers in Surgery and Medicine

Volumn 39, Issue 1, 2007, Pages 8-13

  Chan, Henry H L ^a,b,c   Yang, C H ^a   Leung, Joseph C K ^a   Wei, W I ^a   Lai, K N ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Dermatology and Laser Center   (Hong Kong)

Author keywords

Non ablative; p16; PCNA

Indexed keywords

CYCLINE; DNA; HYPNORM; MIDAZOLAM MALEATE; PROTEIN P16; PROTEIN P16INK4A;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; COOLING; CUTANEOUS PARAMETERS; DNA DAMAGE; IMMUNOHISTOCHEMISTRY; LASER; LIGHT EXPOSURE; MALE; MELANOMA; MORTALITY; MOUSE; NEODYMIUM LASER; NONHUMAN; PHOTOAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; SAFETY; SKIN TUMOR; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

ANIMALS; BIOLOGICAL MARKERS; GENES, P16; LASER THERAPY, LOW-LEVEL; LASERS; MALE; MICE; MICE, INBRED ICR; PROLIFERATING CELL NUCLEAR ANTIGEN; SKIN; TIME;

EID: 33846904012     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20447     Document Type: Article

References (25)

1. Zelickson BD, Kilmer SL, Bernstein E, et al. Pulsed dye laser therapy for sun damaged skin. Lasers Surg Med 1999;25:229-236.
2. Lee MW. Combination visible and infrared lasers for skin rejuvenation. Semin Cutan Med Surg 2002;21:288-300.
3. Goldberg DJ, Silapunt S. Q-switched Nd:YAG laser: Rhytid improvement by non-ablative dermal remodeling. J Cutan Laser Ther 2000;2:157-160.
4. Chan HH, Lam LK, Wong DS, Kono T, Trend-smith N. Use of 1320nm Nd:YAG laser for wrinkle reduction and the treatment of atrophic acne scarring. Lasers Surg Med 2004;34:98-103.
5. Hardaway CA, Ross EV, Paithankar DY. Non-ablative cutaneous remodeling with a 1.45 micron mid-infrared diode laser: Phase II. J Cosmet Laser Ther 2002;4:9-14.
6. Fournier N, Dahan S, Barneon G, Rouvrais C, Diridollou S, Lagarde JM, Mordon S. Nonablative remodeling: A 14-month clinical ultrasound imaging and profilometric evaluation of a 1540 nm Er:Glass laser. Dermatol Surg 2002;28:926-931.
7. Ross EV, Smirnov M, Pankratov M, Altshuler G. Intense pulsed light and laser treatment of facial telangiectasias and dyspigmentation: Some theoretical and practical comparisons. Dermatol Surg 2005;31:1188-1198.
8. Goldberg DJ. Full-face nonablative dermal remodeling with a 1320 nm Nd:YAG laser. Dermatol Surg 2000;26:915-918.
9. Bitter P. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg 2000;26:835-842.
10. Trelles MA, Allones I, Luna R. Facial rejuvenation with a non-ablative 1320 nm Nd:YAG laser: A preliminary clinical and histologic evaluation. Dermatol Surg 2001;27:111-116.
11. Chan HH. Photo-rejuvenation or photoaging: Where does one draw the fine line? J Am Acad Dermatol 2002;47:321-322.
12. Goh SH. A systematic protocol of the Q Switched Nd:Yag laser (Medlite 4 and C6) in aesthetic medicine. Proceedings of the anti-aging symposium, Taipei. September 11, 2005:23.
13. Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Croce CM. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4, in melanoma. Cancer Res 1994;54:5269-5272.
14. Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 1995;10:1061-1067.
15. Dracopoli NC, Fountai JW. CDKN2 mutations in melanoma. Cancer Surv 1996;26:115-132.
16. Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Måsbäck A, Westerdahl J, Olsson H, Ingvar C. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000;92:1260-1266.
17. Chan HH, Xiang L, Leung JW, Tsang KW, Lai KN. An in vitro study examining the effect of sub-lethal QS 755nm lasers on the expression of p16INK4a on melanoma cell lines. Lasers Surg Med 2003;32:88-93.
18. Shivji MK, Kenny MK, Wood RD. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992;69:367-374.
19. Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
20. Katiyar SK, Korman NJ, Mukhtar H, Agarwal R. Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst 1997;89:556-565.
21. Leung AY, Leung JC, Chan LY, Ma ES, Kwan TT, Lai KN, Meng A, Liang R. Proliferating cell nuclear antigen (PCNA) as a proliferative marker during embryonic and adult zebrafish hematopoiesis. Histochem Cell Biol 2005;124:105-111.
22. Raulin C, Greve B, Raulin S. Ethical consideration concerning laser medicine. Lasers Surg Med 2001;28:100-101.
23. Lim HW, Naylor M, Honigsmann H, Gilchrest BA, Cooper K, Morison W, Deleo VA, Scherschun L. American Academy of Dermatology Consensus Conference on UVA protection of sunscreens: Summary and recommendation. J Am Acad Dermatol 2001;44:505-508.
24. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
25. van Schanke A, van Venrooij GM, Jongsma MJ, Banus HA, Mullenders LH, van Kranen HJ, de Gruijl FR. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures. Cancer Res 2006;66:2608-2615.